EYLEA HD® and EYLEA® remained the U.S. anti-VEGF category leader in 2024; aggregate U.S. net product sales were $6 billion for full-year 2024, up 1% based on preliminary (unaudited) results EYLEA HD ...

Lymphoma is a type of cancer that begins in immune system cells, called lymphocytes. It generally presents as a solid tumor of lymphoid cells and can develop in the lymph nodes, spleen ...

Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

diffuse large B-cell lymphoma (DLBCL), primary mediastinal large B-cell lymphoma (PMBCL), and follicular lymphoma grade 3B (FL3B) after two or more lines of systemic therapy. Lisocabtagene maraleucel ...

Blood counts are done every few months, and treatment is initiated if constitutional symptoms (fever, night sweats, fatigue, weight loss greater than 10 percent of body mass), progressive fatigue, ...

In the Mithic-FL1 trial, patients with newly diagnosed high-burden follicular lymphoma (FL) demonstrated complete response (CR) rates of 80% and manageable adverse events with outpatient ...

Liso-cel, a CD19-directed chimeric antigen receptor T-cell product, and mosunetuzumab, a CD20/CD3 bispecific antibody, are used to treat patients with relapsed/refractory follicular lymphoma.

Symptoms of MCL are similar to those of many other types of non-Hodgkin’s lymphoma and may include one or more of the following: Painless, swollen lymph nodes Fevers and night sweats Unintentional ...

B-cell lymphoma is a type of blood cancer that affects the B lymphocytes of the immune system. They usually arise in the lymph nodes or in other lymphoid tissue, such as the spleen, bone marrow ...

When cancer originates in the lymph nodes of the lymphatic system, it is known as lymphoma. Many types of lymphoma exist, defined by their origin, location in the body, and cell characteristics.

The age and pathological type of patients with uterine lymphoma are related, and diffuse large B-cell lymphoma is most common in women aged 35 to 45; Follicular lymphoma is more likely to occur ...